SION - Company ID 0002036042
Sionna Therapeutics, Inc. trades as SION and has a market capitalization of $1.97 B, making it the #2140 largest US-listed company by market value. This page tracks Sionna Therapeutics, Inc. through 198 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Annual report to shareholders | ARS | 2026-04-27 |
| Proxy materials | DEFA14A | 2026-04-27 |
The largest companies sharing Sionna Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Sionna Therapeutics, Inc. (SION) has a market capitalization of $1.97 B as of 2026-07-10, ranking #2140 among US-listed companies.
In its latest fiscal year Sionna Therapeutics, Inc. reported a net loss of $75.27M.